Cgs 20267 T30748+Tab


Indications and Reactions:

Role Indications Reactions
Primary
Breast Cancer 72.3%
Hypertension 10.2%
Hypercholesterolaemia 2.9%
Prophylaxis 2.6%
Arthralgia 1.2%
Diabetes Mellitus 1.2%
Anxiety 0.9%
Asthma 0.9%
Hyperlipidaemia 0.9%
Hypothyroidism 0.9%
Lymphoedema 0.9%
Sleep Disorder 0.9%
Abdominal Pain 0.6%
Arthritis 0.6%
Cardiomyopathy 0.6%
Depression 0.6%
Hypertonia 0.6%
Liver Disorder 0.6%
Uterine Leiomyosarcoma 0.6%
Breast Inflammation 0.3%
Restrictive Cardiomyopathy 14.3%
Malignant Neoplasm Progression 8.6%
Pancytopenia 8.6%
Death 5.7%
Osteoarthritis 5.7%
Pain 5.7%
Vaginal Operation 5.7%
Dementia 4.3%
Metastases To Lymph Nodes 4.3%
Nausea 4.3%
Subarachnoid Haemorrhage 4.3%
Visual Acuity Reduced 4.3%
Visual Impairment 4.3%
Acute Myocardial Infarction 2.9%
Conduction Disorder 2.9%
Fall 2.9%
Gastrointestinal Surgery 2.9%
Headache 2.9%
Hepatic Steatosis 2.9%
Insomnia 2.9%
Secondary
Breast Cancer 83.0%
Prophylaxis 7.5%
Diabetes Mellitus 3.8%
Reflux Oesophagitis 3.8%
Osteopenia 1.9%
Tooth Extraction 33.3%
Hip Fracture 8.3%
Malignant Neoplasm Progression 8.3%
Osteonecrosis 8.3%
Sigmoidectomy 8.3%
Surgery 8.3%
Temporomandibular Joint Syndrome 8.3%
Nausea 4.2%
Percutaneous Coronary Intervention 4.2%
Vaginal Haemorrhage 4.2%
Vein Disorder 4.2%

Drug Data